SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-023353
Filing Date
2021-03-26
Accepted
2021-03-26 20:41:38
Documents
1
Period of Report
2021-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4168
  Complete submission text file 0001209191-21-023353.txt   5603
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CHELSEA THERAPEUTICS, INC. 3530 TORINGDON WAY, SUITE 200 CHARLOTTE NC 28277
Business Address
Oliveto Joseph (Reporting) CIK: 0001437782 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38899 | Film No.: 21779190